NCT04613830 is a Phase 3 clinical trial of Bupivacaine Hydrochloride in Pediatric Cancer, sponsored by Assiut University.

Who is sponsoring NCT04613830?

NCT04613830 is sponsored by Assiut University.

What drugs are being tested in NCT04613830?

Interventions in NCT04613830: Bupivacaine Hydrochloride, Tramadol hydrochloride.

What condition does NCT04613830 study?

NCT04613830 studies Pediatric Cancer.

Is NCT04613830 still recruiting?

NCT04613830 is currently completed. Last updated 3 February 2023.

Last reviewed 2023-02-03 · How we verify

NCT04613830

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Continuous Erector Spinae Block for Post Analgesia in Pediatric Patients

Completed Phase 3 Last updated 3 February 2023

What this trial tests

Phase 3 trial testing Bupivacaine Hydrochloride in Pediatric Cancer in 60 participants. Completed in 1 December 2022.

Timeline

20 November 2020

Primary endpoint
12 November 2022

1 December 2022

Quick facts

Lead sponsor	Assiut University
Phase	Phase 3
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	health services research
Enrollment	60
Start date	20 November 2020
Primary completion	12 November 2022
Estimated completion	1 December 2022
Sites	1 location across Egypt

Drugs / interventions tested

Bupivacaine Hydrochloride (Bupivacaine Hydrochloride) — full drug profile →
Tramadol hydrochloride

Conditions studied

Pediatric Cancer — all drugs for Pediatric Cancer →

Sponsor

Assiut University

Who can join

Adults 2 to 7, any sex, with Pediatric Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate the analgesic efficacy of erector spinae plane block in pediatric cancer patients undergoing open nephrectomy

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Systemic Analgesia versus Continuous Erector Spinae Plane Block (ESPB) Infusion During Paediatric Nephrectomy: A Randomized, Controlled Trial.
Adlan S, Abd El-Rahman A, Mohamed SA, Thabet AM, et al · · 2023 · cited 4× · PMID 37304230 · DOI 10.2147/lra.s401980

Verify or expand the search:

Other trials of Bupivacaine Hydrochloride

Trials testing the same drug.

NCT07512635 — Effect of Intercostal Nerve Block With Liposomal Bupivacaine on Quality of Recovery in VATS Partial Pneumonectomy · Phase 4 · not yet recruiting
NCT06704698 — Postoperative Analgesia Between Paravertebral Block and Epidural Block in Esophageal Surgery · NA · recruiting
NCT06575699 — Rectus Sheath Block for Analgesia After Gynecological Laparotomy · Phase 4 · completed
NCT06577233 — Superior Hypogastric Nerve Plexus Block With Bupivacaine After Robotic Resection of Endometriosis · Phase 4 · recruiting
NCT06569953 — Efficacy and Safety of Liposomal Bupivacaine Injection for Paravertebral Nerve Block in the Treatment of Acute and Chron · Phase 4 · recruiting

Other recruiting trials for Pediatric Cancer

Currently open trials in the same condition.

NCT07506239 — Efficacy of Laser Interstitial Thermal Therapy in Young Persons With Low-grade Glioma · NA · recruiting
NCT07278778 — Cancer Care Companion · NA · recruiting
NCT07473518 — Thyroid Carcinoma in Cancer Patients Undergoing Radiotherapy · recruiting
NCT06939322 — LOG-I - Impact Study of LOG-AFTER Software on Long-term Monitoring of Former Patients (LOG-I - LOG-Impact Study) · NA · recruiting
NCT07188311 — Pucotenlimab Combined With Lenvatinib and Chemotherapy in the Treatment of Advanced, Relapsed/Refractory Hepatoblastoma · NA · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04613830 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 3 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04613830.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing